New Jersey judge decides Bausch Health's Xifaxan is 'prior art,' does not infringe Curia patents
You win some, you lose some. And in New Jersey federal court on Wednesday, Bausch Health won.
About a month after a Delaware court found …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
